FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313473009> ?p ?o ?g. }

• W4313473009 endingPage "240" @default.
• W4313473009 startingPage "240" @default.
• W4313473009 abstract "Background: Although some sepsis cases were reported with immune checkpoint inhibitors (ICIs) in clinical trials, the link between pulmonary sepsis and ICIs remains mostly unknown. We aim to investigate the association between pulmonary sepsis and ICIs, and to describe the clinical features. Methods: A disproportionality analysis was performed using FAERS data and compared rates of pulmonary sepsis in cancer patients receiving ICIs vs. other drug regimens (such as chemotherapy and targeted therapy). Associations between ICIs and sepsis were assessed using reporting odds ratios (ROR) and information component (IC). We also detected drug interaction signals based on the Ω shrinkage measure. Age and gender distribution were compared between pulmonary sepsis and all adverse events associated with ICIs. Results: We identified 120 reports of pulmonary sepsis associated with ICIs between Q1, 2011 to Q3, 2021. A total of 82 of 120 (68.3%) patients on ICIs suffered from pulmonary sepsis and progressed to death. In addition, there is no significant difference in age and gender in the occurrence of pulmonary sepsis in cancer patients on ICIs. Overall ICIs, nivolumab, and atezolizumab still have a significant signal of pulmonary sepsis (ROR025 > 1, IC025 > 0, p < 0.001) compared with targeted therapy (such as tyrosine kinase inhibitors) or chemotherapy. Co-administration of ICIs and glucocorticoids or proton pump inhibitors synergistically increased the risk of pulmonary sepsis (Ω025 > 0). Conclusions: Our study suggested ICIs, especially nivolumab and atezolizumab, tended to increase the risk of pulmonary sepsis more than other anticancer regimens. Clinicians should be vigilant in the prevention and management of pulmonary sepsis during ICIs therapy." @default.
• W4313473009 created "2023-01-06" @default.
• W4313473009 creator A5000245959 @default.
• W4313473009 creator A5004686702 @default.
• W4313473009 creator A5008622494 @default.
• W4313473009 creator A5027734392 @default.
• W4313473009 creator A5058344667 @default.
• W4313473009 creator A5065452686 @default.
• W4313473009 creator A5065598852 @default.
• W4313473009 creator A5071616245 @default.
• W4313473009 creator A5090747400 @default.
• W4313473009 date "2022-12-30" @default.
• W4313473009 modified "2023-09-25" @default.
• W4313473009 title "Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study" @default.
• W4313473009 cites W1898928487 @default.
• W4313473009 cites W2005366883 @default.
• W4313473009 cites W2015487160 @default.
• W4313473009 cites W2098730643 @default.
• W4313473009 cites W2128464732 @default.
• W4313473009 cites W2158299492 @default.
• W4313473009 cites W2280404143 @default.
• W4313473009 cites W2396212074 @default.
• W4313473009 cites W2462118923 @default.
• W4313473009 cites W2747272999 @default.
• W4313473009 cites W2765639474 @default.
• W4313473009 cites W2779221466 @default.
• W4313473009 cites W2783137027 @default.
• W4313473009 cites W2808829764 @default.
• W4313473009 cites W2891486030 @default.
• W4313473009 cites W2947945944 @default.
• W4313473009 cites W2965623006 @default.
• W4313473009 cites W2988170839 @default.
• W4313473009 cites W3000696551 @default.
• W4313473009 cites W3003167633 @default.
• W4313473009 cites W3007899322 @default.
• W4313473009 cites W3023436560 @default.
• W4313473009 cites W3029420556 @default.
• W4313473009 cites W3062134476 @default.
• W4313473009 cites W3088384582 @default.
• W4313473009 cites W3097304584 @default.
• W4313473009 cites W3097703961 @default.
• W4313473009 cites W3158943590 @default.
• W4313473009 cites W3170368056 @default.
• W4313473009 cites W3193337461 @default.
• W4313473009 cites W3198320927 @default.
• W4313473009 cites W3202323220 @default.
• W4313473009 cites W3204988028 @default.
• W4313473009 cites W4223614330 @default.
• W4313473009 cites W4226329559 @default.
• W4313473009 cites W4285306252 @default.
• W4313473009 cites W4308722228 @default.
• W4313473009 doi "https://doi.org/10.3390/cancers15010240" @default.
• W4313473009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36612235" @default.
• W4313473009 hasPublicationYear "2022" @default.
• W4313473009 type Work @default.
• W4313473009 citedByCount "4" @default.
• W4313473009 countsByYear W43134730092023 @default.
• W4313473009 crossrefType "journal-article" @default.
• W4313473009 hasAuthorship W4313473009A5000245959 @default.
• W4313473009 hasAuthorship W4313473009A5004686702 @default.
• W4313473009 hasAuthorship W4313473009A5008622494 @default.
• W4313473009 hasAuthorship W4313473009A5027734392 @default.
• W4313473009 hasAuthorship W4313473009A5058344667 @default.
• W4313473009 hasAuthorship W4313473009A5065452686 @default.
• W4313473009 hasAuthorship W4313473009A5065598852 @default.
• W4313473009 hasAuthorship W4313473009A5071616245 @default.
• W4313473009 hasAuthorship W4313473009A5090747400 @default.
• W4313473009 hasBestOaLocation W43134730091 @default.
• W4313473009 hasConcept C121608353 @default.
• W4313473009 hasConcept C126322002 @default.
• W4313473009 hasConcept C156957248 @default.
• W4313473009 hasConcept C177713679 @default.
• W4313473009 hasConcept C197934379 @default.
• W4313473009 hasConcept C2775949291 @default.
• W4313473009 hasConcept C2776256026 @default.
• W4313473009 hasConcept C2777701055 @default.
• W4313473009 hasConcept C2778384902 @default.
• W4313473009 hasConcept C2780030458 @default.
• W4313473009 hasConcept C57658597 @default.
• W4313473009 hasConcept C71924100 @default.
• W4313473009 hasConceptScore W4313473009C121608353 @default.
• W4313473009 hasConceptScore W4313473009C126322002 @default.
• W4313473009 hasConceptScore W4313473009C156957248 @default.
• W4313473009 hasConceptScore W4313473009C177713679 @default.
• W4313473009 hasConceptScore W4313473009C197934379 @default.
• W4313473009 hasConceptScore W4313473009C2775949291 @default.
• W4313473009 hasConceptScore W4313473009C2776256026 @default.
• W4313473009 hasConceptScore W4313473009C2777701055 @default.
• W4313473009 hasConceptScore W4313473009C2778384902 @default.
• W4313473009 hasConceptScore W4313473009C2780030458 @default.
• W4313473009 hasConceptScore W4313473009C57658597 @default.
• W4313473009 hasConceptScore W4313473009C71924100 @default.
• W4313473009 hasFunder F4320317581 @default.
• W4313473009 hasIssue "1" @default.
• W4313473009 hasLocation W43134730091 @default.
• W4313473009 hasLocation W43134730092 @default.
• W4313473009 hasLocation W43134730093 @default.
• W4313473009 hasLocation W43134730094 @default.

• next